Bleb Vascularity and the Outcomes After Trabeculectomy
Study Details
Study Description
Brief Summary
-
Study objective: To evaluate the relationship between filtering bleb vascularity and the surgical outcomes after trabeculectomy
-
Study design: A prospective study of 51 eyes of 44 patients after primary MMC-augmented trabeculectomy. The follow-up was 12 months.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Total vessel area of a filtering bleb was measured with ImageJ software on colour photographs of a filtering bleb on day 1, 14, 1, 3 and 6 months and 1 year after trabeculectomy. Blebs were classified clinically as successful (IOP below 18 mmHg and a >30% reduction in IOP without antiglaucoma medications or additional surgical interventions) or failed. Linear regression analysis was performed to determine the correlation of the bleb vascularity with IOP.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
patients after primary MMC-augmented trabeculectomy
|
Outcome Measures
Primary Outcome Measures
- Rates of surgical success [1 year]
The successful bleb group consisted of eyes with IOP below 18 mmHg and a >30% reduction in IOP at 1 year after surgery without antiglaucoma medications or additional surgical interventions. Failed blebs were defined when IOP was over 18 mmHg, below 18 mmHg with antiglaucoma medications or if any additional surgical intervention was necessary
Secondary Outcome Measures
- Correlation of Bleb vascularity with IOP [6 months]
Linear regression analysis was performed to determine the correlation of the bleb vascularity with IOP
Eligibility Criteria
Criteria
Inclusion Criteria:
-
primary open angle glaucoma (POAG) with medically uncontrolled intraocular pressure (IOP)
-
pseudoexfoliation glaucoma (PEXG) with medically uncontrolled intraocular pressure (IOP)
Exclusion Criteria:
-
primary angle closure glaucoma (PACG)
-
secondary glaucoma except PEXG
-
previous eye surgery
-
subjects with decreased vision due to other reasons than glaucoma (e.g., exudative age-related macular degeneration (AMD), proliferative diabetic retinopathy, inflammatory eye diseases)
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Medical University of Lublin
Investigators
- Study Chair: Tomasz Żarnowski, MD, PhD, Professor, Medical University in Lublin
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- KE-0254/203/2014